Phase 3 Trials

Cambridge, Massachusetts & Hangzhou, China, April 20, 2026 In a significant strategic move within the biopharmaceutical industry, Biogen Inc....

Bagsværd, Denmark – March 27, 2026 Novo Nordisk announced that the U.S. FDA has approved Awiqli® (insulin icodec-abae), the...

SAINT-HERBLAIN, FRANCE — November 26, 2025. Valneva has announced positive final Phase 2 results for its Lyme disease vaccine...

TARRYTOWN, N.Y. & PARIS — November 25, 2025. The European Commission has granted landmark approval for Dupixent® (dupilumab) as...

Titusville, New Jersey – November 6, 2025 – Johnson & Johnson (NYSE: JNJ) announced that the U.S. Food and...

RAHWAY, N.J. – October 15, 2025 — Merck (NYSE: MRK) announced new Phase 3 trial results for its investigational,...